Main focus: Many different therapeutic areas e.g. oncology, cardiovascular, neuroscientific and more.
Company stage: Commercial
Genome editing technology: CRISPR-Cas9
Funding stage: Public (NASDAQ:AZN)
Location: Cambridge, England
AstraZeneca is a public, clinical stage big pharma company focused on a wide array of therapeutic areas. The company has existed for many years and pursues many innovative areas of therapy. AstraZeneca has worked with CRISPR therapeutic models on several occasions. The company showed the ability for CRISPR to reverse a mutation causing enzyme defficiency in a mouse model. The company is also working closely with several global laboratories to develop new CRISPR tools such as CRISPR GUARD, CRISPR VIVO and DISCover-seq.